You are here: All Products  > Ocumension Acquires China Rights to Uveitis Treatment in $12 Million Agreement

Ocumension Acquires China Rights to Uveitis Treatment in $12 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products